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Abstract There is need for a valid and reliable biomarker 
for HIV Associated Neurocognitive Disorder (HAND). The 
purpose of the present study was to provide preliminary 
evidence of the potential utility of neuronal functional con-
nectivity measures obtained using magnetoencephalography 
(MEG) to identify HIV-associated changes in brain function. 
Resting state, eyes closed, MEG data from 10 HIV-infected 
individuals and 8 seronegative controls were analyzed using 
mutual information (MI) between all pairs of MEG sensors 
to determine whether there were functional brain networks 
that distinguished between subject groups based on cogni-
tion (global and learning) or on serostatus. Three networks 
were identified across all subjects, but after permutation 
testing (at a<.005) only the one related to HIV serostatus 
was significant. The network included MEG sensors (planar 
gradiometers) above the right anterior region connecting to 
sensors above the left posterior region. A mean MI value 
was calculated across all connections from the anterior to 
the posterior groupings; that score distinguished between 
the serostatus groups with only one error (sensitivity^ 
1.00, specificity-88 (X2=15.4, df=l, p<.01, Relative 
Risk=.ll). There were no significant associations between 
the MI value and the neuropsychological Global Impairment 
Rating, substance abuse, mood disorder, age, education, 
CD4+ cell counts or HIV viral load. We conclude that using 
a measure of functional connectivity, it may be possible to 
distinguish between HIV-infected and uninfected individu-
als, suggesting that MEG may have the potential to serve as 
a sensitive, non-invasive biomarker for HAND. 
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Introduction 
HIV-Associated Neurocognitive Disorder (HAND) affects 
the management, survival, and quality of life of affected 
patients and their families (Bridge 1988). Although the 
incidence of HIV-associated dementia (HAD) is falling, 
the prevalence of the milder forms of HIV-related cognitive 
disorders, such as Mild Neurocognitive Disorder (MNCD) 
is rising (Sacktor et al. 2001; Sacktor et al. 2002; Cysique et 
al. 2004). One major weakness in the field of NeuroAIDS is 
the lack of a useful neuroimaging biomarker for HAD and 
MNCD (Antinori et al. 2005); these are clinical syndromes, 
and laboratory tests and standard clinical neuroimaging are 
used largely to exclude alternative causes rather than direct-
ly establishing a diagnosis (Navia and Rostasy 2005). A 
biomarker would also be important to determine whether 
the CNS processes are pathologically active (for example, as 
found by magnetic resonance spectroscopy (Chang et al. 
2003, 2004b; Paul et al. 2007)) prior to clinical onset (i.e., 
Asymptomatic Neurocognitive Impairment). Further, 
because the effectiveness of treatment on CNS structure/ 
function is sometimes uncertain, a biomarker that more 
objectively assesses treatment outcomes is needed (See 
(Price et al. 2007) for a review). 
One technology that has not been applied to HIV disease 
is magnetoencephalography (MEG), a non-invasive tech-
nique for monitoring neuronal activity in the brain that is 
based on recording magnetic fields induced by synchronized 
intracellular currents in populations of neurons. Under ideal 
conditions, MEG can measure the activity of synchronously 
firing neurons with a spatial resolution of a few millimeters 
and a submillisecond temporal resolution. Thus, MEG 
provides "a more direct index of sensory, motor, and cog-
nitive task-specific activation compared with methods that 
rely on hemodynamic measures" (Papanicolaou et al. 
2004, p. 869). 
The high temporal resolution of MEG allows fine-
grained analysis of functional connectivity through the mea-
surement of the dynamics of the oscillatory activity, and 
establishing the functional interaction between brain regions 
in specific frequency bands (e.g., (Stam et al. 2006)). The 
statistical correlation between any two magnetic time series 
can be measured through linear and nonlinear methods 
including spectral coherence, phase synchronization, or gen-
eralized synchronization. Long-range synchronization 
between signals originating in relatively distant neuronal 
populations is one potential mechanism for communication 
and integration of information in the brain (Várela et al. 
2001; Fries 2005; Engel et al. 2001). Studies of elderly 
individuals with mild cognitive impairment have shown that 
alterations in functional connectivity precede the develop-
ment of clinical dementia and are related to the time to 
develop dementia (Bajo et al. 2011; Bajo et al. 2010). The 
purpose of this pilot study is to analyze MEG data from a 
group of patients with HIV disease and risk-group appropri-
ate controls to determine the extent to which measures of 
functional connectivity could serve as a useful CNS 
biomarker of HIV infection. 
Methods 
Subjects 
10 HIV-infected and 8 seronegative controls participated in 
this research. All subjects were 40-65 years old, and all but 
one of the participants was male. The risks for HIV infection 
included having unprotected sex with men (among the men 
only) and using illicit injection drugs. We were not able to 
confirm infection with Hepatitis C in these subjects. This 
sample of convenience was drawn from existing, ongoing 
studies of HIV Disease, cognition and the brain. 
All of the subjects were right-handed (Oldfield 1971), and 
native English speakers. None had histories of ADD/ADHD 
or other developmental disabilities (by self report). The sub-
jects did not have active drug/alcohol abuse or dependence, 
current major depression, or a history of neurological disease, 
CNS Opportunistic Infections, CNS tumors, or clinical stroke. 
There were no significant differences between the groups in 
terms of age, education, or estimated reading skill (grade level 
equivalent). With the exception of executive functions, there 
were no differences between groups in terms of the Domain 
Impairment Ratings (See Table 1). 
All of the HIV-infected patients were on combination anti-
retroviral therapy at the time of the study. Only one had a 
current CD4+ cell count of less than 500 (spec, 422). With 
one exception (spec, 3520 copies), all of these participants had 
current viral loads less than 300 (and 4 were undetectable). 
Procedures 
Neuropsychological studies A detailed neuropsychological 
examination was completed at study entry and after 
24 weeks. The evaluation included measures from multiple 
cognitive domains including Memory, Language, Visual-
Construction, Psychomotor Speed, Motor and Executive 
Table 1 Characteristics of study participants as a function of seros-
tatus (MeaniS.D.) 
Seronegative Seropositive Statistics8 
Number 8 10 
Age 53.0 (6.5) 50.5 (4.8) .96, .23 
Education 14.4 (1.7) 14.4 (2.0) -.34, .08 
CD4+ Cell Count n/a 776.0 (268) n/a 
Viral Load (logi0) n/a 583.4 (1297) n/a 
Mood Disorder 75(6) 6(50) .09, -.07 
Substance Abuse Disorder 75(6) 5(50) .54, -.17 
Grade Level Reading 12.4 (1.3) 11.6 (2.3) .85, .20 
Cognitive Functions 
Executive 1.56 (1.0) 2.90 (1.4) -2.4, .50* 
Fluency 2.25 (1.3) 2.80 (1.5) -.90, .21 
Attention 1.50 (.53) 1.80 (.63) -.91, .22 
Speed 1.88(1.1) 2.90 (2.2) -1.2, .29 
Learning 3.00 (3.6) 3.40 (2.7) .18, .04 
Memory 3.00 (3.5) 4.10 (2.6) -.31, .08 
Motor 1.13 (.44) 2.10 (2.1) -1.2, .28 
Spatial 1.13 (.71) 2.20 (1.8) -1.3, .31 
Global 3.38 (3.4) 4.20 (2.3) -.15, .04 
Global Impairment N(%) Abnormal 50(4) 60(6) .46, .16 
Learning Impairment N(%) Abnormal 38(3) 40(4) .09, .07 
ñt andr, o rZ 2 and Phi 
N (%) meeting criteria for history of disorder 
*p<.05 
functions, and provided the necessary information to com-
plete the diagnostic adjudication using the HAND Consen-
sus Diagnostic criteria (Antinori et al. 2007). These scores 
ranged from Normal [1-3], through Borderline [4], to five 
grades of impaired performance [5-9]. 
Psychosocial evaluation Each participant underwent a semi-
structured diagnostic interview, and completed questionnaires 
concerning psychiatric symptomatology. The components of 
the evaluation were: i) a modified Structured Clinical Interview 
for DSM-EI-R (Spitzer et al. 1990); ii) the Brief Symptom 
Inventory (Derogatis and Spencer 1982) and the Neuropsychi-
atric Inventory (Cummings et al. 1994) to assess subclinical 
psychiatric symptoms, and ifi) Heaton's Patient Assessment of 
Own Functioning questionnaire (Heaton and Pendelton 1981) 
and the Modified Instrumental Activities of Daily Living scale 
(Lawton and Brody 1969) to provide information about the 
specific symptoms of cognitive decline, and their impact on 
activities of daily living. For the purpose of this pilot study, 
these data were used only as part of the process of determining 
the presence of HAND and relevant comorbidities. 
Structural MR study Each subject had an MRI exam of the 
brain for use with the MEG data, and for an analysis of brain 
structural integrity. The scans were completed on a Siemens 
3 T TIM Trio using a protocol that was modified from that 
of the Alzheimer's Disease Neuroimaging Initiative (Mueller 
et al. 2005). The sagittal Magnetization Prepared Rapid 
Acquisition Gradient Echo (MP-RAGE) sequence was: 
FOV=256 mm; slices=160; TR=2300 ms; TE=2.91 ms; 
TI=900 ms; Flip angle=9°; slice thickness=1.2 mm. 
MEG data collection The Elekta Neuromag® (Elekta Oy, 
Helsinki, Finland) MEG system was used for all MEG 
recordings. The system has 102 magnetometers and 204 
planar gradiometers in a helmet-shaped array covering the 
entire scalp. The magnetometers measure the overall mag-
nitude of the magnetic field component approximately nor-
mal to the head surface; the gradiometers measure the 
difference of that field component at two adjacent locations. 
Eye movements were monitored by simultaneously record-
ing an electrooculogram. The MEG sensor unit, the floor-
mounted gantry, the movable subject chair, together with the 
patient audio-visual monitoring and stimulus delivery sys-
tems, were all contained in a magnetically shielded room 
(Imedco AG, Hágendorf, Switzerland). 
The participants were seated with their head in the MEG 
sensor helmet that covered the entire head except the face. 
Four head position indicator coils (HPI) were placed on the 
scalp, appropriately spaced in the region covered by the MEG 
helmet. The locations of the nasion, two preauricular points, 
and the four HPI coils were digitized prior to each MEG study 
using a 3D-digitizer (ISOTRAK; Polhemus, Inc., Colchester, 
VT) to define the subject-specific Cartesian head coordinate 
system. An additional 30-50 anatomical points were digitized 
on the head surface to provide for a more accurate co-
registration of the MEG data with the reconstructed volumet-
ric MR image. Once a subject was comfortably positioned in 
the MEG machine, short electrical signals were sent to the HPI 
coils to localize them with respect to the MEG sensor array 
The data from the HPI coils were used to correct for within-
session head movement by each study participant. 
MEG data were acquired at a sampling rate of 1 kHz, 
with on-line filtering of 0.10-330 Hz. Acquisition occurred 
in a single session comprising two runs separated by 
approximately a 10-minute break. The first run included 
two memory tasks, while the second run included the same 
two memory tasks, as well as 10 min of "resting state" data; 
5 min with eyes open followed by 5 min with eyes closed. 
Only the resting state data were analyzed for this report, and 
because "global" artifacts such as eye blinks easily con-
found many of the functional connectivity measures, only 
the eyes-closed data were used. 
MEG connectivity analysis 
All of the MEG data were de-identified and sent to the 
Laboratory of Cognitive and Computational Neuroscience, 
and Center for Biomedical Technology at the Complutense 
and Technical Universities of Madrid (RB, PC, FM) for 
connectivity analysis. The neuropsychological Domain 
scores and the Global Impairment Rating were dichoto-
mized as Normal/Borderline vs. Impaired (See Woods and 
colleagues (Woods et al. 2004) for details). The binary 
scores for the Learning Domain and for Global Impairment, 
as well as a variable indicating subject serostatus were 
renamed (e.g., VAR001) and also sent to the team in 
Madrid. The MI analysis was tested relative to each of these 
three grouping variables (500 permutations each, see be-
low); the data analysts were unaware of the meaning of 
the three classification variables (i.e., blind analysis). 
The MEG data were visually inspected by an experienced 
investigator (RB) prior to analysis. Traces with artifacts due 
to eye movements or muscular artifacts were rejected before 
computing the connectivity analysis. We calculated Mutual 
Information (MI) using in-house Fortran code and imple-
mented the MI algorithm as described by Hlavácková-
Schindler and colleagues (Hlavácková-Schindler et al. 
2007). The MI calculations were done separately for the 
102 magnetometers units and the two sets of 102 gradiom-
eters units. This gave us three symmetric and weighted 
correlation matrices of 102x102 elements per analysis. 
The values in the matrix ranged from -0.05 to -0.50. 
Because the MI values were always greater than zero, there 
was some degree of dependence between all the nodes. The 
initial analysis was run with all sensors, but we report here 
only the results from the planar gradiometers. 
To compare the MI between the 2 groups, a Kruskal-
Wallis test was calculated for each channel pair. Nonpara-
metric permutation tests (M. D. Ernst 2004; Nichols and 
Holmes 2002; Holmes et al. 1996) were used to find those 
channel pairs with significant differences between groups. 
This was done by randomly dividing the 18 participants into 
2 groups to match the size of the original groups (based on 
the cognitive and serostatus classification variables). Then 
we repeated the two-sample Kruskal-Wallis test between 
these two new groups for each channel pair. This was 
repeated 500 times and the p value from each test for each 
channel pair was retained in order to obtain a distribution of 
p values for each channel pair. We then identified the 5th 
percentile of each distribution, and only the p values below 
that threshold were accepted. 
Results 
The connectivity analyses using the binary scores for Learn-
ing Domain and Global Impairment variables as grouping 
factors were only significant at/><.05, and therefore were 
not considered reliable. By contrast, the solution using the 
serostatus variable was significant at ¿><.005 (using 500 
permutations to establish the null distribution). Figure 1 
Fig. 1 The pairs of sensors that showed significant Mutual Informa-
tion (i.e., below the 5th percentile of the distribution) that distinguished 
the seropositive from the seronegative subjects. The top of the sensor 
map is the front of the head, and the right side of the map corresponds 
to the right side of the head 
shows the pairs of sensors that showed significant (i.e., below 
the 5th percentile of the distribution) MI and that distinguished 
the seropositive from the seronegative subjects. 
We computed a variable that reflected the extent of the 
MI in each individual subject by selecting the two groups of 
gradiometers where we found significant statistical differ-
ences (See Fig. 2a). We calculated the mean MI between 
each of the three sensors in the right anterior region, and 
each of the five sensors in the left posterior region. This 
mean MI value was able to distinguish between the two 
subject groups at a cut-off value of 0.075 with only one 
error, yielding a sensitivity of 1.00 and a specificity of .88 
(See Fig. 2b) (X2=15.4, df=l, p<.01, Relative Risk-11 
(95% confidence interval .02-.71)(See Figs. 2b and 3). With 
the exception of the Executive Domain Rating (t(17)=-2.31, 
p—.03), there were no significant associations between the 
mean MI value and any of the cognitive Domain ratings, the 
Global Impairment rating, or a history of substance abuse or 
mood disorder (See Table 2). There was no significant 
association between the MI value and the current CD4+ cell 
count (r=-.ll) or logio viral load (r=-.ll) among the HIV-
infected subjects. 
Discussion 
Brain function is commonly studied from the standpoint of 
functional segregation or specialization by localizing cogni-
tive functions in specific brain regions (see (Friston 1994; 
Friston et al. 1993; Buechel and Friston 1997) for discus-
sion). However, advanced statistical analysis techniques 
Fig. 2 The upper graphic a 
shows the map of the pairs of 
sensors that were used to create 
the Mutual Information score. 
The lower graphic b shows the 
Mutual Information scores for 
each individual participant as a 
function of serostatus (red = 
HIV+, blue = HIV-) 
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allow us to study the relationships among brain regions and 
how they affect behavior (Mcintosh et al. 1994); that is, 
functional integration studied with functional connectivity 
(Herbster et al. 1996), typically defined as a statistical inter-
dependence between neurophysiological data that are 
recorded simultaneously from several brain regions. 
Our data show that alterations in functional connectivity 
as revealed by the mean MI values distinguish between HIV 
infected patients and uninfected controls. This measure of 
MI was unrelated to measures of cognitive function (except 
executive function), mood state or measures of clinical 
status. One hypothesis arising from these data is that the 
Fig. 3 The mean Mutual Information score for the HIV-infected sub-
jects and the seronegative controls (± 1 s.d. unit) 
altered connectivity reflects HIV-related functional and pos-
sibly structural changes in the brain that occurred during the 
time when viral replication was not well controlled. This 
hypothesis is consistent with our prior observation that 
neuropsychological test performance is related to the time 
since infection, independent of age (e.g., (Becker et al. 
2011)). This idea is also supported by our failing to find a 
link between the MI value and current CD4+ cell counts or 
viral load; we did not have nadir CD4+ or peak viral load 
data available for analysis. 
An alternative hypothesis is that our observations reflect 
the effects of a chronic, low-grade process related to HIV 
infection that persists even in the presence of good virolog-
ical control (Chang et al. 2003; Chang et al. 2004a; Chang 
et al. 2002; T. Ernst et al. 2002). In a future study, this 
hypothesis could be tested by examining metabolic markers 
such as n-acetyl aspartame and myoinositol, reflecting neu-
ronal integrity and glial activity, using magnetic resonance 
spectroscopy and correlating the levels of these markers 
with the MI values obtained with MEG. 
Another way to distinguish between these two hypothe-
ses would be to study patients during the acute recovery 
from HAD using HAART. We would predict that during the 
time that the patients had HAD, they would show the 
abnormal MI level. To the extent that the altered connectiv-
ity reflects the effects of the initial insult, then we would 
predict recovery of function with therapy to be accompanied 
by recovery of the MI value to normal levels. This would 
follow because the time of uncontrolled viral replication 
would be relatively short. On the other hand, to the extent 
Table 2 Characteristics of study participants as a function of MI 
classification (Mean±S.D.) 
MI Group 1 MI Group 2 Statistics3 
Number 8 11 
Mean MI Value .115 (.02) .040 (.02) 8.1,.89 ** 
Age 53.5 (6.7) 50.4 (4.6) 1.2, .28 
Education 13.9(1.6) 14.6 (2.0) -.78, .19 
Mood Disorder 5(63) 7(63) .003, .012 
Substance Abuse Disorder 6(75) 5(46) 1.66, -.30 
HIV Seropositive0 0(0) 91 (10) 15.4, .90 ** 
Grade Level Reading 12.3 (1.4) 11.7(2.2) .63, .15 
Cognitive Functions 
Executive 1.50(1.1) 2.82 (1.3) -2.31, .48* 
Fluency 2.38 (1.3) 2.64 (1.5) -.40, .10 
Attention 1.50 (.54) 1.82 (.60) -1.19, .28 
Speed 2.00(1.1) 2.73 (2.2) -.86, .20 
Learning 4.00 (3.7) 3.18(2.7) .11, .14 
Memory 4.00 (3.6) 3.82 (2.6) .13, .03 
Motor 1.25 (.46) 2.00(2.1) -1.00, .24 
Spatial 1.38 (.74) 2.09 (1.8) -1.01, .25 
Global 4.38 (3.5) 3.91 (2.4) .35, .08 
Global Impairment 38(3) 36(4) .003, -.01 
Learning Impairment 50(4) 55(6) .038, .05 
a i and r, or X and Phi for serostatus, and impairment 
N (%) meeting criteria for history of disorder 
°N(%) HIV infected 
*/)<-05 
**/)<.001 
that there is an ongoing, chronic, low-grade process second-
ary to the infection, then we would predict that the MI levels 
would not recover to normal, as these processes would be 
unaffected by HAART. 
A recent study by Wang and colleagues (Wang et al. 
2011) is directly relevant to our results. They identified eight 
functional networks during eyes-open rest using an indepen-
dent components analysis of whole brain BOLD images. Of 
these networks, they found that one involving the lateral 
occipital cortex was under-expressed in their HIV-infected 
subjects (« = 15) compared to the uninfected controls (n= 
15). Perhaps most interesting was that they found that the 
locus of the difference was in the left inferior parietal cortex 
within the LOC network, which would generally correspond 
to the posterior regions that we found with our analysis. 
These results complement our findings—we report a long 
distance functional abnormality between right anterior and 
left posterior sensors, and Wang and colleagues report a 
local functional abnormality in the left posterior region 
(see their Fig. 2c). One critical implication of their data is 
the importance of moving our MI analysis into source space, 
and directly comparing those findings to BOLD fMRI, 
while building further on the superior temporal resolution 
of MEG. 
One strength of our study is that we did not specify a 
priori a specific network to be evaluated. That is, we 
allowed the data to tell us whether or not it was possible 
to differentiate the groups of patients based on a pattern of 
functional connectivity rather than testing whether a specific 
network was altered in the patient groups. This has the 
advantage of not restricting the network that might be iden-
tified (much like brain-wide, voxel-level analyses permit the 
identification of unexpected patterns of brain atrophy). 
However, one potential weakness of this analytic strategy 
is that we necessarily completed a very large number of 
comparisons to calculate the MI maps. We took several 
steps to minimize the effects of multiple comparisons and 
the risk of Type I error. First, we used the non-parametric 
Kruskal-Wallis test, which is reliable and relatively conser-
vative. Second, we employed permutation analysis at the 
subject level; we tested whether the between-group differ-
ences found in the data were significantly larger than those 
in the random permutations along the spatial/temporal axis. 
This analysis creates new distributions of the subject's sen-
sor space data to evaluate whether the differences obtained 
by the original distribution are stronger than those obtained 
by the 500 artificial ones. We obtained a Monte Carlo 
/?-value that takes into account the /"-values obtained from 
the 500 permutations. Third, we chose a conservative sig-
nificance threshold (a=.005) for accepting a network as 
reliable. Finally, we emphasize that the MI analysis was 
done blind—the investigators in Madrid received only 
binary codes (i.e., 0/1) with non-informative names (e.g., 
VAR001). 
This is a small-scale, cross-sectional, observational study 
with all of the attendant limitations. We could not, for exam-
ple, disentangle the (potentially) independent relationships 
among the MI score, HIV serostatus and executive system 
functions because there were no HIV+participants with high 
MI scores. However, when we did an exploratory analysis by 
regressing the MI score on serostatus and executive function 
domain score, only serostatus was significantly linked to MI. 
Further, all of our HIV+participants were healthy, with all but 
one showing little (or undetectable) viral replication, with 
CD4+ cell counts generally >500. They had all been infected 
(and treated) for more than 10 years, so we could not evaluate 
the impact of early therapy on the MEG data. In addition, 
because these analyses were conducted in sensor space, we 
did not take advantage of the spatial resolution of the MEG 
data. Clearly, future studies will need to include analyses in 
source (i.e., brain) space, in order to directly compare/contrast 
functional and structural changes secondary to HIV disease. 
However, while these questions are important and need to be 
addressed, they were beyond the restricted scope of the current 
project. 
Our data are nonetheless provocative in that they offer 
the possibility that MEG may be able to reveal HIV-
associated alterations in brain function that have not been 
detected to date with other neuroimaging methods. We have 
previously shown that MEG data are stable over 6 months 
(Becker, et al., Under Editorial Review), and that it may be 
possible to disentangle HIV-related effects from those relat-
ed to cognitive functions based on differences in relative 
power across frequency bands. Thus, MEG may become a 
useful addition to clinical trials. However, before that can be 
fully assessed, it will be necessary to first gather additional 
data from a larger group of subjects, including more women, 
with a wider range of cognitive performance, and a greater 
variability in virological and immunological control. 
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